Skip to content
777 Sourcing.

Capability

clinical-stage therapeutic development

Suppliers
2
States & provinces
2
Countries
1

2 clinical-stage therapeutic development suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

Arisan Therapeutics is a clinical-stage biotechnology company focused on the discovery and development of novel oral therapeutics for emerging infectious diseases and metabolic disorders. It is advancing government-funded small-molecule programs for Ebola virus disease and Lassa fever, and exploring applications of a clinical-stage small-molecule platform in cardiometabolic disorders including hypertriglyceridemia, visceral adiposity, MASLD/MASH, and obesity-related conditions.

small-molecule drug discovery and development

Beyond Barriers Therapeutics (BBT) is a clinical-stage biotechnology company developing BBT-101, a first-of-its-kind intranasal therapeutic designed to mitigate the damaging secondary effects of mild traumatic brain injuries (mTBI, also known as concussions) and moderate TBIs. The company began as the brainchild of University of Chicago and Northwestern graduate students who in 2015 won the NIH Neuro Startup Challenge. BBT is affiliated with the University of Miami through a research collaboration with Dr. Michael Hoffer.

intranasal drug delivery

Related capabilities

Other processes offered by the shops that list clinical-stage therapeutic development.

Browse all capabilities